type: timeline_event
On April 3, 2020, President Trump issued an executive order under the Defense Production Act prohibiting the export of N95 respirators, surgical masks, and other scarce personal protective equipment. The order was directed prominently at 3M, which Trump had publicly attacked for selling masks to foreign buyers while American hospitals went without. However, the export ban revealed the administration's selective and incoherent use of emergency powers: while Trump was willing to restrict exports, he still refused to issue broad production mandates that would have compelled domestic manufacturers to scale up PPE manufacturing at set prices. The result was an export ban layered on top of a chaotic domestic market in which price gouging ran rampant and states were forced to bid against one another and against the federal government for supplies.
The dysfunction was compounded by FEMA's aggressive seizure of PPE shipments that states and hospitals had procured independently. Governors reported that orders they had placed and paid for were being intercepted by federal agents, redirected into the national stockpile, and then redistributed through opaque channels that appeared to favor politically allied states. When pressed on this at a White House briefing, Jared Kushner infamously declared that the Strategic National Stockpile was "our stockpile" and "not supposed to be states' stockpiles," a statement that laid bare the administration's view that federal emergency resources were political assets rather than public goods. States responded by arranging secret procurement operations, with some governors using back channels and even National Guard escorts to prevent federal seizure of incoming shipments.
The export ban episode exposed a profiteering ecosystem that flourished in the absence of comprehensive DPA enforcement. Without mandatory production orders setting prices and allocating output, a shadow market of brokers, middlemen, and speculators emerged, purchasing PPE at normal prices and reselling it at markups of 500 to 1,000 percent. Some of these brokers had connections to administration officials and politically connected firms. The selective use of the DPA to restrict trade while refusing to control domestic production and pricing created the worst of both worlds: it antagonized international allies who depended on American-made PPE, particularly 3M products, while doing nothing to address the fundamental shortage that was driving the crisis. The administration's approach demonstrated that the Defense Production Act's powers were being deployed not to maximize public health outcomes but to generate political leverage and protect corporate pricing autonomy.